# ABACAVIR SULFATE AND LAMIVUDINE
> **ANDA205412** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-04-16
## Drug
- **FDA Application Number:** ANDA205412
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE AND LAMIVUDINE
- **Generic name:** ABACAVIR AND LAMIVUDINE
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2025-04-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205412)
---
*MORVS · CC0 1.0*